upsid guid stock look cheap
like set-up ci think compani built
conservat guidanc see potenti strong driven better sg cost
trend control specialti busi work finish strand
overhead cost antm departur pbm volum come back in-
hous number yet like upsid ci screen cheap
us ep reiter overweight rate
bridg guid show conservat built think bull case mid-high
see potenti mid-year guidanc boost could come
call histor largest guid boost newli schedul
i-day sinc june run math think buffer put
conservat also like repeat interest expens go
ramp could land number mid high rang year
start report non-repeat comm indiv out-performance
guidanc debt cap manag intend pay upper
rang month could remov annual interest expens
achiev adjust estim reflect new guid
ci first comment hh rebat reg post last night announc
big pictur dont see materi effect ci earn whole
partli due scale impact busi line part mapd caid also esrx
current rebat structur esrx pass back rebat script
custom contract pass rebat model flag rebat
guarante headwind note esrx visibl deceler trend
environ took appropri action servic contract
varianc contract term swap ci volum
pull back volum year ahead schedul ci bring back
next replac lost volum exactli term
believ outsourc rebat claim process technolog custom
servic network contract procur deliveri formulari manag
prior author specialti rx strategi esrx split ci outsourc
similar except believ ci manag rebat handl
prior author believ could area ci challeng replic unh
precheck myscript larg instal base believ materi part
fourth-largest health insur focu non-risk product
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
price guidanc tabl
reiter ow rate pt pt base unchang ep
unchang risk achiev price target includ lower expect synergi benefit esrx deal
healthcar reform reimburs higher expect cost trend
compani data pjc estim
page
digitmid-singl digitpharmaci claim pharmaci guidanceguid jan risk pt
overweight feb close pt pt made
ep risk includ increas medic cost trend reimburs competit
overweight feb close pt pt made
ep risk includ data protect increas medic cost trend premium price competit
page
thousand except per share
fee revenu
medic benefit expens
premium
compani report piper jaffray co current disclosur inform compani found http //www piperjaffray com/researchdisclosur
